HES1 and nonpapillary renal cell carcinoma: Of note, our results demonstrated that miR-138–2 prohibits the malignant phenotypes of ccRCC cells, indicating that miR-138–2 contributes to the efficient inactivation of NOTCH1-HES1 signaling pathway.